Table 1 GRID2IP expression association with clinical characteristics (logistic regression)
Characteristics | Total (N) | Odds Ratio(OR) | P value |
|---|---|---|---|
T stage (T3&T4 vs. T1&T2) | 641 | 1.231 (0.838–1.812) | 0.291 |
N stage (N1&N2 vs. N0) | 640 | 1.789 (1.305–2.460) |  < 0.001 |
M stage (M1 vs. M0) | 564 | 2.421 (1.508–3.970) |  < 0.001 |
Pathologic stage (Stage III&Stage IV vs. Stage I&Stage II) | 623 | 2.001 (1.453–2.765) |  < 0.001 |
Age (> 65 vs. ≤65) | 644 | 1.079 (0.790–1.475) | 0.633 |
Residual tumor (R1&R2 vs. R0) | 510 | 1.815 (0.954–3.581) | 0.075 |
CEA level (> 5 vs. ≤5) | 415 | 2.025 (1.350–3.059) |  < 0.001 |
Primary therapy outcome (PD&SD&PR vs. CR) | 312 | 1.160 (0.645–2.100) | 0.621 |
Lymphatic invasion (Yes vs. No) | 582 | 2.055 (1.468–2.889) |  < 0.001 |
BMI (≥ 25 vs. < 25) | 329 | 1.645 (1.035–2.627) | 0.036 |